FDA Warning Letter — K.C. Pharmaceuticals, Inc.

Case 654986 — FEI 2026940

The FDA took a Warning Letter action against K.C. Pharmaceuticals, Inc. on Aug 3, 2023 (Pomona, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
K.C. Pharmaceuticals, Inc.
Date
Aug 3, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Pomona, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.